Recombinant gp160 as a therapeutic vaccine for HIV-infection: results of a large randomized, controlled trial-Reference-Cited by-同舟云学术

Recombinant gp160 as a therapeutic vaccine for HIV-infection: results of a large randomized, controlled trial

Published:1999-08 Issue:12 Volume:13 Page:1461-1468
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:AIDS

Author:

Goebel Frank-D.,Mannhalter Josef W.,Belshe Robert B.,Eibl Martha M.,Grob Peter J.,de Gruttola Victor,Griffiths Paul D.,Erfle Volker,Kunschak Marianne,Engl Werner

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference35 articles.

1. Immunization of chimpanzees confers protection against challenge with human immunodeficiency virus.

2. Protection of MN-rgp120-Immunized Chimpanzees from Heterologous Infection with a Primary Isolate of Human Immunodeficiency Virus Type 1

3. Protection of Macaques Against SIV Infection by Subunit Vaccines of SIV Envelope Glycoprotein gp160

4. Recombinant subunit vaccines as an approach to study correlates of protection against primate lentivirus infection

5. Protection against lethal simian immunodeficiency virus SIVsmmPBj14 disease by a recombinant Semliki Forest virus gp160 vaccine and by a gp120 subunit vaccine

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Human Immunodeficiency Virus (HIV);Transfusion Medicine and Hemotherapy;2016

2. Humanes Immunschwächevirus (HIV);Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz;2015-10-20

3. Advances in Nanomedicine Towards Clinical Application in Oncology and Immunology;Current Pharmaceutical Biotechnology;2014-11-07

4. Immune Intervention in AIDS;Immunology of Infectious Diseases;2014-04-09

5. HIV-1 matrix protein p17: A candidate antigen for therapeutic vaccines against AIDS;Pharmacology & Therapeutics;2010-12